Scholars Central

Conference abstractPublished 2019

Targeting cancer with selective and potent ruthenium compounds

Authors: Andreia Valente, Leonor Corte-Real, M Helena Garcia

University of Lisbon, Portugal

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Statement of the Problem: The discovery of new active and selective anticancer agents, able to reduce the noxious side effects of the chemotherapeutics in clinical use, and able to overcome resistance mechanisms, is the main goal for the research in this field. Methodology & Theoretical Orientation: We have been developing new of [Ru(η5-C5H5) (2,2′-bipyridine-R)(PPh3)]+ based compounds through structure-activity studies, endowed with specific targeting components to take advantage of the singular characteristics of tumor cells and tissues, such as their permeability to macromolecules and overexpression of several receptors. Thus, when in the structure of our compounds R is a biodegradable and biocompatible polymer and/or a biomolecule recognized by cancer cells, passive and/ or active targeting can be achieved, respectively. Through a wide set of biological assays that involved spectroscopic, imaging and proteomic techniques, we show that this family of ruthenium metallodrugs possess very attractive features. Conclusion & Significance: These compounds show high cytotoxicity against several cancer cell lines with different degrees of aggressiveness (eg. hormone dependent vs triple negative breast cancer) and strong inhibition of key proteins known for their role in mechanisms of cell resistance. Their targets seem to be the proteins that regulate the microtubule or actin dynamics leading to cell death by apoptosis. In vivo studies in a zebrafish model revealed that the compounds are well tolerated. Thus, in this presentation the potential of new ruthenium(II) compounds for the targeted therapy of metastatic and resistant cancers is disclosed.

Subjects

Biology

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Cell Biology: Research & Therapy.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalCell Biology: Research & Therapy
  • SubjectBiology
  • BylineArticles whose byline prints “Andreia Valente”
  • BylineArticles whose byline prints “Leonor Corte-Real”
  • BylineArticles whose byline prints “M Helena Garcia”